246 related articles for article (PubMed ID: 28904201)
1. Heterogeneity of the Epstein-Barr Virus (EBV) Major Internal Repeat Reveals Evolutionary Mechanisms of EBV and a Functional Defect in the Prototype EBV Strain B95-8.
Ba Abdullah MM; Palermo RD; Palser AL; Grayson NE; Kellam P; Correia S; Szymula A; White RE
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904201
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
Tierney RJ; Kao KY; Nagra JK; Rickinson AB
J Virol; 2011 Dec; 85(23):12362-75. PubMed ID: 21957300
[TBL] [Abstract][Full Text] [Related]
3. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.
Majerciak V; Yang W; Zheng J; Zhu J; Zheng ZM
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355690
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.
Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE
PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212
[TBL] [Abstract][Full Text] [Related]
5. Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.
Rivailler P; Cho YG; Wang F
J Virol; 2002 Dec; 76(23):12055-68. PubMed ID: 12414947
[TBL] [Abstract][Full Text] [Related]
6. Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.
Palser AL; Grayson NE; White RE; Corton C; Correia S; Ba Abdullah MM; Watson SJ; Cotten M; Arrand JR; Murray PG; Allday MJ; Rickinson AB; Young LS; Farrell PJ; Kellam P
J Virol; 2015 May; 89(10):5222-37. PubMed ID: 25787276
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.
Walling DM; Perkins AG; Webster-Cyriaque J; Resnick L; Raab-Traub N
J Virol; 1994 Dec; 68(12):7918-26. PubMed ID: 7966582
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
9. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis.
Falk K; Gratama JW; Rowe M; Zou JZ; Khanim F; Young LS; Oosterveer MA; Ernberg I
J Gen Virol; 1995 Apr; 76 ( Pt 4)():779-90. PubMed ID: 9049323
[TBL] [Abstract][Full Text] [Related]
10. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
Lupton S; Levine AJ
Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
[TBL] [Abstract][Full Text] [Related]
11. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
Rooney C; Howe JG; Speck SH; Miller G
J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
[TBL] [Abstract][Full Text] [Related]
13. Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection.
Weiss ER; Lamers SL; Henderson JL; Melnikov A; Somasundaran M; Garber M; Selin L; Nusbaum C; Luzuriaga K
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093087
[TBL] [Abstract][Full Text] [Related]
14. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
15. Limited sequence heterogeneity of Epstein-Barr virus nuclear antigen 1 in benign and malignant EBV-associated disorders.
Schuster V; Ott G; Seidenspinner S; Kreth HW
Infection; 2000; 28(3):137-42. PubMed ID: 10879636
[TBL] [Abstract][Full Text] [Related]
16. Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization.
Yoo LI; Woloszynek J; Templeton S; Speck SH
J Virol; 2002 Nov; 76(22):11763-9. PubMed ID: 12388739
[TBL] [Abstract][Full Text] [Related]
17. A global phylogenetic analysis of Japanese tonsil-derived Epstein-Barr virus strains using viral whole-genome cloning and long-read sequencing.
Yajima M; Kakuta R; Saito Y; Kitaya S; Toyoda A; Ikuta K; Yasuda J; Ohta N; Kanda T
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33433312
[TBL] [Abstract][Full Text] [Related]
18. EBNA-1 sequence variations reflect active EBV replication and disease status or quiescent latency in lymphocytes.
Wang JT; Sheeng TS; Su IJ; Chen JY; Chen MR
J Med Virol; 2003 Mar; 69(3):417-25. PubMed ID: 12526054
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
Sample J; Young L; Martin B; Chatman T; Kieff E; Rickinson A; Kieff E
J Virol; 1990 Sep; 64(9):4084-92. PubMed ID: 2166806
[TBL] [Abstract][Full Text] [Related]
20. Distinctive effects of the Epstein-Barr virus family of repeats on viral latent gene promoter activity and B-lymphocyte transformation.
Ali AK; Saito S; Shibata S; Takada K; Kanda T
J Virol; 2009 Sep; 83(18):9163-74. PubMed ID: 19570868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]